Profil
Marleen Johanna Limbourg was the founder of Sneezz BV, a company founded in 2017, where she held the title of Chief Marketing Officer from 2017 to 2021.
She is currently the Director at Bingli NV and THERAtRAME SA, both starting in 2022.
Additionally, she is a Board Member at Vlaams Instituut voor Biotechnologie - Flanders Institute since 2018 and an Investment Manager at Noshaq SA since 2022.
In her former positions, she was the Director of Medical & Scientific Affairs at TiGenix NV from 2011 to 2014 and the Director of Global Medical Affairs at UCB SA from 2005 to 2010.
Dr. Limbourg obtained a doctorate degree from Katholieke Universiteit Leuven in 1997 and an MBA from Vlerick Leuven Gent Management School in 2005.
Postes actifs de Marleen Johanna Limbourg
| Sociétés | Poste | Début |
|---|---|---|
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage. | Private Equity Investor | 01/01/2022 |
Bingli NV
Bingli NV Data Processing ServicesTechnology Services Processes, manages and storages of information in medical sector | Directeur/Membre du Conseil | 27/02/2022 |
THERAtRAME SA
THERAtRAME SA BiotechnologyHealth Technology Discovers and develops tRNA epitranscriptomics molecules for cancer | Directeur/Membre du Conseil | 01/08/2022 |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/02/2018 |
Anciens postes connus de Marleen Johanna Limbourg
| Sociétés | Poste | Fin |
|---|---|---|
Sneezz BV
Sneezz BV Medical/Nursing ServicesHealth Services Engages in helping allergic persons suffering from allergies in the air or hay fever through information and scientific insight | Fondateur | 01/01/2021 |
| TIGENIX NV | Corporate Officer/Principal | 01/01/2014 |
| UCB | Corporate Officer/Principal | 01/01/2010 |
Formation de Marleen Johanna Limbourg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
UCB SA
UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlerick Leuven Gent Management School
Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage. | Finance |
Bingli NV
Bingli NV Data Processing ServicesTechnology Services Processes, manages and storages of information in medical sector | Technology Services |
Sneezz BV
Sneezz BV Medical/Nursing ServicesHealth Services Engages in helping allergic persons suffering from allergies in the air or hay fever through information and scientific insight | Health Services |
THERAtRAME SA
THERAtRAME SA BiotechnologyHealth Technology Discovers and develops tRNA epitranscriptomics molecules for cancer | Health Technology |
















